Govind Babu

2.2k total citations
90 papers, 524 citations indexed

About

Govind Babu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Govind Babu has authored 90 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 16 papers in Otorhinolaryngology. Recurrent topics in Govind Babu's work include Head and Neck Cancer Studies (16 papers), Lymphoma Diagnosis and Treatment (11 papers) and Oral Health Pathology and Treatment (11 papers). Govind Babu is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Lymphoma Diagnosis and Treatment (11 papers) and Oral Health Pathology and Treatment (11 papers). Govind Babu collaborates with scholars based in India, United Kingdom and United States. Govind Babu's co-authors include Linu Abraham Jacob, D. Lokanatha, M. Babu, KC Lakshmaiah, Kumar Prabhash, Gita Bhat, L K Rajeev, Munish Gairola, Lokanatha Dasappa and Sumit Goyal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Govind Babu

77 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Govind Babu India 12 222 147 102 88 82 90 524
Reggie Duerst United States 17 213 1.0× 221 1.5× 91 0.9× 151 1.7× 112 1.4× 42 902
Michael Jaglal United States 12 148 0.7× 57 0.4× 84 0.8× 35 0.4× 96 1.2× 78 420
Christopher Fraser Australia 13 261 1.2× 218 1.5× 49 0.5× 45 0.5× 62 0.8× 33 799
Mukta Pujani India 15 156 0.7× 78 0.5× 72 0.7× 162 1.8× 87 1.1× 81 702
Raja Pramanik India 14 222 1.0× 126 0.9× 75 0.7× 130 1.5× 35 0.4× 95 574
Samuel Vokurka Czechia 14 333 1.5× 358 2.4× 152 1.5× 23 0.3× 82 1.0× 50 669
Jonathan Cotliar United States 12 300 1.4× 156 1.1× 102 1.0× 129 1.5× 52 0.6× 30 825
Simona Secondino Italy 18 687 3.1× 227 1.5× 85 0.8× 168 1.9× 111 1.4× 59 1.2k
Sam Penza United States 17 321 1.4× 59 0.4× 118 1.2× 47 0.5× 88 1.1× 63 806
Pedro Zubizarreta Argentina 18 437 2.0× 93 0.6× 102 1.0× 113 1.3× 90 1.1× 59 986

Countries citing papers authored by Govind Babu

Since Specialization
Citations

This map shows the geographic impact of Govind Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Govind Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Govind Babu more than expected).

Fields of papers citing papers by Govind Babu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Govind Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Govind Babu. The network helps show where Govind Babu may publish in the future.

Co-authorship network of co-authors of Govind Babu

This figure shows the co-authorship network connecting the top 25 collaborators of Govind Babu. A scholar is included among the top collaborators of Govind Babu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Govind Babu. Govind Babu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jha, Prerana, Rohit Mishra, Neha Sharma, et al.. (2025). Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience. PubMed. 8. 100300–100300. 1 indexed citations
2.
Parikh, Purvish M., Akhil Kapoor, Tarini Prasad Sahoo, et al.. (2024). Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC). SHILAP Revista de lepidopterología. 14(1). 45–52. 1 indexed citations
3.
Jha, Prerana, Rohit Mishra, Sewanti Limaye, et al.. (2024). Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients. Clinical Lung Cancer. 25(8). e420–e430.e20. 2 indexed citations
4.
Parikh, Purvish M., Govind Babu, Randeep Singh, et al.. (2023). Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method. BMC Cancer. 23(1). 714–714. 3 indexed citations
5.
Nanda, Ranjan Kumar, et al.. (2021). Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance. Reports of Practical Oncology & Radiotherapy. 26(6). 948–954. 6 indexed citations
6.
Bajpai, Jyoti, Reena Nair, Sudeep Gupta, et al.. (2020). Gender climate in Indian oncology: national survey report. ESMO Open. 5(2). e000671–e000671. 15 indexed citations
7.
Prabhash, Kumar, Govind Babu, Pankaj Chaturvedi, et al.. (2020). Indian clinical practice consensus guidelines for the management of oropharyngeal cancer. Indian Journal of Cancer. 57(5). 12–12. 7 indexed citations
8.
9.
Prabhash, Kumar, Govind Babu, Pankaj Chaturvedi, et al.. (2020). Indian clinical practice consensus guidelines for the management of very advanced disease of squamous cell carcinoma of head and neck. Indian Journal of Cancer. 57(5). 22–22. 5 indexed citations
10.
Rajeev, L K, et al.. (2018). Epithelioid Sarcoma Presenting as Recurrent Thumb Ulcer: a Lesson to Learn. Indian Journal of Surgical Oncology. 9(2). 251–253. 2 indexed citations
11.
Babu, Govind, Linu Abraham Jacob, M. Babu, et al.. (2018). Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients. Annals of Oncology. 29. ix129–ix129. 3 indexed citations
12.
Babu, Govind, et al.. (2018). Extranodal NK/T cell lymphoma- nasal type: Experience from an Indian regional cancer centre. Annals of Oncology. 29. ix89–ix90.
13.
Jacob, Linu Abraham, KC Lakshmaiah, Govind Babu, et al.. (2018). Repeat biopsy a must in recurrent breast cancer: A study from tertiary cancer centre in India. Annals of Oncology. 29. ix16–ix17.
14.
Babu, Govind, D. Lokanatha, Linu Abraham Jacob, et al.. (2018). A prospective phase III randomized study to evaluate the efficacy of olanzapine for prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy (HEC). Annals of Oncology. 29. ix129–ix129. 1 indexed citations
15.
Lakshmaiah, K C, Govind Babu, Lokanatha Dasappa, et al.. (2017). Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases. Indian Journal of Cancer. 54(3). 526–526. 10 indexed citations
16.
Lakshmaiah, KC, et al.. (2017). Evolution of the treatment of primary central nervous system lymphoma in a Regional Cancer Center of South India: Impact of high-dose methotrexate on treatment outcome. Journal of Cancer Research and Therapeutics. 16(1). 13–13. 1 indexed citations
17.
Lakshmaiah, K C, et al.. (2017). Primary central nervous system lymphoma in immunocompetent patients: A regional cancer center experience. South Asian Journal of Cancer. 6(4). 165–168. 7 indexed citations
18.
Babu, Govind, et al.. (2017). P1.01-057 Metastatic Lung Cancer at a Tertiary Cancer Centre in South India. Journal of Thoracic Oncology. 12(1). S484–S485. 1 indexed citations
19.
20.
Babu, Govind, et al.. (2015). Adenocarcinoma of Lung Presenting as Unilateral Blindness: A Case Report. 3(2). 62–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reggie Duerst Breakdown of academic impact, for papers by Michael Jaglal Breakdown of academic impact, for papers by Christopher Fraser Breakdown of academic impact, for papers by Mukta Pujani Breakdown of academic impact, for papers by Raja Pramanik Breakdown of academic impact, for papers by Samuel Vokurka Breakdown of academic impact, for papers by Jonathan Cotliar Breakdown of academic impact, for papers by Simona Secondino Breakdown of academic impact, for papers by Sam Penza Breakdown of academic impact, for papers by Pedro Zubizarreta
Rankless by CCL
2026